Forskolin is extracted from the roots of the Indian coleus (Coleus forskohlii), a tropical plant related to the mint family. Forskolin compound is a diterpene that plays a major role in the reduction of inflammation.

The global Forskolin market was valued at US$ million in 2020 and is expected to reach US$ million by the end of 2027, growing at a CAGR of % during 2021-2027.
This report focuses on Forskolin volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Forskolin market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.

Global Forskolin Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
Low Purity(Below 97%)
Purity(Above 97% and Below 99%)
High Purity(Above 99%)
Others

Segment by Application
Weight Management
Respiratory Disorders
Digestive Disorders
Insomnia
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

By Company
Sabinsa Corporation
Bioprex Labs
Nutra Green Biotechnology
Varion Lifesciences
Glentham Life Sciences
Manus Aktteva Biopharma